All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-22524831
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 22524831 A2926G
E2
E2
Uterine Cervical Neoplasms
G
R
S
View
2 22524831 C3410T
E2
E2
Uterine Cervical Neoplasms
G
R
S
View
3 22524831 G2826A
E2
E2
Uterine Cervical Neoplasms
G
R
S
View
4 22524831 G7193T
LCR
Uterine Cervical Neoplasms
G
R
S
View
5 22524831 G7521A
LCR
Uterine Cervical Neoplasms
G
R
S
View
6 22524831 G7060A
L1
L1
Uterine Cervical Neoplasms
G
R
S
View
7 22524831 G7060T
L1
L1
Uterine Cervical Neoplasms
G
R
S
View
8 22524831 A647G
E7
E7
Uterine Cervical Neoplasms
G
R
S
View
9 22524831 N29S
E7
E7
Uterine Cervical Neoplasms
G
R
S
View
10 22524831 C335T
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
11 22524831 D25E
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
12 22524831 G145T
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
13 22524831 H78Y
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
14 22524831 L83V
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
15 22524831 Q14H
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
16 22524831 T178G
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
17 22524831 T350G
E6
E6
Uterine Cervical Neoplasms
G
R
S
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.